MediKredit Integrated Healthcare Solutions (Pty) Ltd Reg No :1995/001794/07 Head Office : Johannesburg Cape Town S witchboard: Switchboard: Telkom: +27 (0) 11 770-6000 Neotel: +27 (0) 11 589-6000 Facsimile: Facsimile: +27 (0) 11 770/589-6001 Call Centre: +27 (0) 860-932-273
Please find below a summary of the May 2011 industry news, happenings and regulatory matters for
your attention. If you have any queries on the matters below, you are most welcome to contact your
Business Operations Specialist, Relationship Manager or myself for further discussion or if you
require copies of any of the publications, gazettes or CMS publications mentioned below.
1. The Council for Medical Schemes
• CMS Circular 17 of 2011: Comment invited on definition of BDs In the CMS Circular 17 of 2011 published on 13 May 2011, the CMS have invited affected
stakeholders to submit written comment, including the cost impact of the Benefit Definitions (BDs) in
accordance with the data col ection sheet, by 10 June 2011.
The CMS commenced a process during 2010 to better define PMB benefits through the
development of explicit BDs for PMB conditions prescribed in the PMB regulations. As part of the
process the CMS has received stakeholder submissions, established advisory committees to
consider the submissions and have developed draft BDs.
• CMS Press Release 19 of 2011: Former members of Protea Medical Scheme are protected
In light of the fact that Protea Medical Scheme has recently been placed under provisional liquidation,
the legal unit of the CMS have published a press release dated 25 May 2011 as a reminder that the
Medical Schemes Act prescribes that any member who wishes to join a medical scheme must be
al owed to do so and be admitted to the open medical scheme of his/her choice.
Al open medical schemes are therefore legal y obliged to admit former members of Protea Medical
Scheme without engaging in any form of discrimination.
Directors: Dr S C P Belamant; A W Brunyee; W J du Plessis ; H G Kotzé
• CMS Press Release 3 of 2011: The CMS has announced that Bonitas has been placed under curatorship
The CMS has announced that Bonitas has been placed under curatorship and that the South
Gauteng High Court has appointed Mr. Joseph Maluleke as the curator on 27 May 2011.
Based on this ruling, the scheme’s Board of Trustees and acting Principal Officer have been removed
from office and replaced by the curator.
The CMS further elaborated that the need for a curator is not in any way a reflection on the financial
stability of the scheme or on its ability to honour claims. Bonitas remains one of the biggest and
healthiest medical schemes in South Africa. At the end of 2009 Bonitas had more than 650 000
• CMS Circular 18 of 2011: Schemes notification of dates for the holding of scheme meetings and elections
In the CMS Circular 18 of 2011 published on 23 May 2011, the CMS are requesting the medical
schemes to notify them of the dates for the holding of scheme meetings and elections.
This circular is a cal upon al medical schemes to notify CMS in writing:
Of a date on which a medical scheme intends to hold an AGM or special general meeting;
Of a date on which a medical scheme intends to hold trustee elections.
This circular is effective immediately upon release.
• CMS Circular 20 of 2011: Pro-ration of benefits upon resignation / termination of membership CMS Circular 20 of 2011 was published on 30 May 2011 in respect of pro-ration of benefits upon
resignation / termination of membership.
Regulation 9 of the Medical Schemes Act states as fol ows:
“9. Limits on benefits
A medical scheme may, in respect of the financial year in which a member joins the scheme,
reduce the annual benefits with the exception of the prescribed minimum benefits, pro-rata to
the period of membership in the financial year concerned calculated from the date of admission
to the end of the financial year concerned.”
The correct application of Regulation 9 applies when a member is admitted during the course of a
financial year and the benefits are adjusted in proportion to the period of membership, calculated from
the date of admission to the end of the particular financial year.
However, Regulation 9 has been interpreted to imply that benefits may be applied retrospectively if
the member resigns or terminates membership during the same year of joining the scheme. There is
no basis for this interpretation and Medical Schemes and administrators are requested to refrain from
such an interpretation with immediate effect.
2. Legislature
• COIDA Annual Increase in Medical Tariffs for Medical Service Providers, Pharmacies and Hospital Groups
In the government gazette dated 24 May 2011, it sets out the amended Annual Increase in Medical
Tariffs for Medical Service Providers, Pharmacies and Hospital Groups in terms of COIDA for the
The fees appearing in these Schedules are applicable in respect of services rendered on or after 1 April 2011 and excludes VAT.
• Health Budget Vote Policy speech by Minister of Health: Dr A Motsoaledi
The Health Budget Vote Policy speech was delivered by the Minister of Health: Dr A Motsoaledi to the
National Assembly on 31 May 2011.
In this speech the Minister highlighted the fol owing issues:
The budget of the Health Sector 2011/12 to 2013/14 financial years
In his speech the health Minister announced that the Department of Health is currently working hard
in preparing the ground for the implementation of the National Health Insurance (NHI). The minister
stated that “for us the NHI involves more than the release of the document. It involves an extensive
preparation of the health system while at the same time preparing a policy document".
The NHI cannot be sustained by the current health care system which means that both the
public and the private wil be completely re-engineered. The present health care system is
characterized by 4 very clearly defined negatives:
It is very hospicentric or curative in nature.
The abovementioned re-engineering of the Health Care System wil be accordingly 3 main
A district based model. A team of 5 specialist or clinicians shal be deployed in each
district who wil focus on maternal and child mortality.
School Health Programme. This wil be launched with the Ministers of Basic Education
A ward based PHC model. 10 wel trained PHC workers wil be deployed per ward.
The budget of the Health Sector 2011/12 to 2013/14 financial years:
The health department's budget has increased from 21,7 bil ion in the 2010/11 financial year to
25,7 bil ion in the 2011/12 financial year. This is an increase of 15,3%.
The Minister also announced additional funding of R692 mil ion for the financial year 2012/13;
R2, 276 bil ion in the financial year 2013/4 for the improvement of the quality of health,
strengthening of primary healthcare teams and the improvement of maternal and child health in
3. General
• Stats SA General Household Survey 2010
The General Household Survey (GHS) 2010 was conducted by Statistics South Africa (Stats SA) in
Household access to services and facilities
Summary of key findings pertaining to health:
Public clinics (60,8%) were the most frequently used health facilities among sampled individuals,
fol owed by a private doctor (24,3%) and a public hospital (9,4%).
The vast majority of households (91,1%) used the nearest facility of its kind. Those who did not
use the nearest health facility general y travel ed elsewhere and did so mainly because they felt
that the waiting period was too long at their nearest facility (10,3%).
Nearly a quarter (24,3%) of South African households had at least one member who belonged to
A relatively smal proportion (17,6%) of the individuals in South Africa had medical aid coverage in
2010. The Western Cape (24,4%) and Gauteng (26,5%) had the highest percentage of medical
aid membership while Limpopo (8,6%), Eastern Cape (12,1%) and Northern Cape (13,6%) had
the lowest proportion of medical aid members. White people were much more likely to belong to a
medical aid scheme than individuals from other population groups.
• MCC withdraws license for Avandia
The Medicines Control Council (MCC) has issued a notice to withdraw registration for Avandia, a
diabetes drug manufactured by GlaxoSmithKline (GSK). The decision fol ows that of their
counterparts in Europe over safety concerns. The US Food and Drug Administration (FDA) is also
concerned about Avandia's safety, and although they have yet to withdraw Avandia, they has
restricted its use to specific patients.
Avandia (active ingredient rosiglitazone), was designed for treating type 2 diabetes. Due to the drug’s
relative high cost it has not been available to state patients in South Africa and has only been used to
Matthew Dijkstra
MediKredit Integrated Healthcare Solutions (Pty) Limited
Direct Number: +27 11 770 6411 Cell Number: +27 72 230 4490 Email:[email protected]
Thyroid Science 3(1):C1-2, 2008 www.ThyroidScience.com Editorial Dr. Kenneth Blanchard’s False Beliefs About T Therapy Dr. John C. Lowe* *19 Long Springs Place, The Woodlands, TX 77382 USA, www.drlowe.com Contact: [email protected], January 10, 2008, I received the fol-were the two doctors she heavily quoted. Since read-lowing question from a person expressing concern
On 6 February 2010 ABN AMRO Bank N.V. (registered with the Dutch Chamber of Commerce under number 33002587) changed its name to The Royal Bank of Scotland N.V. and on 1 April 2010 ABN AMRO Holding N.V. changed its name to RBS Holdings N.V. and all references in the attached document to " ABN AMRO Bank N.V. " should be read as references to " The Royal Bank of Scotland N.V. &